{"DataElement":{"publicId":"3135349","version":"1","preferredName":"Bladder Carcinoma Pathologic M Stage","preferredDefinition":"Alphanumeric code to represent the spread of bladder carcinoma from the primary tumor site to distant anatomic sites, based on pathologic assessment and staging guidelines from the AJCC edition 7.0.","longName":"2190106v1.0:3135306v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"2190106","version":"1","preferredName":"Bladder Tumor Pathologic M Stage","preferredDefinition":"Information related to pathologic M stage of a bladder tumor.","longName":"BLAD_TUMOR_P_M","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"2206698","version":"1","preferredName":"Bladder Neoplasm","preferredDefinition":"A distensible musculomembranous organ serving as a receptacle for fluid, as the gallbladder.:(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.","longName":"C12414:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bladder","conceptCode":"C12414","definition":"The distensible sac-like organ that functions as a reservoir of urine, collecting from the kidneys and eliminating via the urethra.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-008F-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2207807","version":"1","preferredName":"Pathologic M Stage","preferredDefinition":"Pathologic; caused by or altered by or manifesting disease or pathology.:One criteria of the TMN staging system.  M refers to the presence of metastasis.","longName":"C25610:C25727","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic","conceptCode":"C25610","definition":"Caused by or altered by or manifesting disease or pathology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"M Category","conceptCode":"C25727","definition":"One criteria of the TNM staging system. M refers to the presence of metastasis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-30F5-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E6CD6331-E5A0-480C-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-10-19","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-10-19","modifiedBy":"TAYLORT","dateModified":"2018-11-28","changeDescription":"10/9/17 tt transferred context/BC; added Reg Status.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3135306","version":"1","preferredName":"Bladder Carcinoma Pathologic M Stage","preferredDefinition":"A carcinoma arising from the bladder epithelium.  Approximately 90% of the bladder carcinomas are transitional cell carcinomas.  The remainder are squamous cell carcinomas, adenocarcinomas and small cell neuroendocrine carcinomas._Caused by or altered by or manifesting disease or pathology._One criteria of the TNM staging system.  M refers to the presence of metastasis.","longName":"3135306v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"2","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"M1","valueDescription":"Distant Metastasis","ValueMeaning":{"publicId":"2558673","version":"1","preferredName":"Distant Metastasis","longName":"2558673","preferredDefinition":"Refers to cancer that has spread from the original (primary) tumor to distant organs or distant lymph nodes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Distant Metastasis","conceptCode":"C18206","definition":"A biological process that involves the transfer and growth of cancer cells from the site of the primary tumor. Relocation of malignant cells during metastasis can be restricted to movement within a specific tissue/organ or may entail migration to a distal locus within the body. This phenotype is a characteristic of all malignant tumors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B23E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"REEVESD","dateModified":"2010-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8FBEF763-FE20-BCFA-E040-BB89AD433126","beginDate":"2002-02-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-08","modifiedBy":"ONEDATA","dateModified":"2010-09-08","deletedIndicator":"No"},{"value":"M0","valueDescription":"Bladder Cancer cM0 TNM Finding v7","ValueMeaning":{"publicId":"3165465","version":"1","preferredName":"Bladder Cancer cM0 TNM Finding v7","longName":"3165465","preferredDefinition":"Bladder cancer without evidence of distant metastasis. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bladder Cancer cM0 TNM Finding v7","conceptCode":"C89364","definition":"Bladder cancer without evidence of distant metastasis. (from AJCC 7th Ed.)","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"96D7AA2D-0965-EB1F-E040-BB89AD436E93","latestVersionIndicator":"Yes","beginDate":"2010-12-07","endDate":null,"createdBy":"WHITES","dateCreated":"2010-12-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC:American Joint Committee on Cancer Cancer Staging Manual, 7th Ed., 2009","id":"96D7AA2D-097E-EB1F-E040-BB89AD436E93","beginDate":"2010-12-07","endDate":null,"createdBy":"WHITES","dateCreated":"2010-12-07","modifiedBy":"ONEDATA","dateModified":"2010-12-07","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3135305","version":"1","preferredName":"Bladder Carcinoma Pathologic M Stage Stage","preferredDefinition":"A carcinoma arising from the bladder epithelium.  Approximately 90% of the bladder carcinomas are transitional cell carcinomas.  The remainder are squamous cell carcinomas, adenocarcinomas and small cell neuroendocrine carcinomas.:Pathologic; caused by or altered by or manifesting disease or pathology.:One criteria of the TMN staging system.  M refers to the presence of metastasis.:The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"C4912:C25610:C25727:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bladder Carcinoma","conceptCode":"C4912","definition":"A carcinoma arising from the bladder epithelium.  Approximately 90% of the bladder carcinomas are transitional cell carcinomas.  The remainder are squamous cell carcinomas, adenocarcinomas and small cell neuroendocrine carcinomas.","evsSource":"CTCAE_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Pathologic","conceptCode":"C25610","definition":"Caused by or altered by or manifesting disease or pathology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"M Category","conceptCode":"C25727","definition":"One criteria of the TNM staging system. M refers to the presence of metastasis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8FBEF763-FDFA-BCFA-E040-BB89AD433126","latestVersionIndicator":"Yes","beginDate":"2010-09-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-08","modifiedBy":"ONEDATA","dateModified":"2010-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC:American Joint Committee on Cancer Cancer Staging Manual, 7th Ed., 2009","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8FBEF763-FE0B-BCFA-E040-BB89AD433126","latestVersionIndicator":"Yes","beginDate":"2010-09-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-08","modifiedBy":"WHITES","dateModified":"2010-12-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2756809","version":"1","longName":"TCGA (The Cancer Genome Atlas)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6044924","version":"1","longName":"Inactive CDEs as of March 2017","context":"NCIP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Distant Spread: Distant Metas","type":"Preferred Question Text","description":"Distant Spread: Distant Metastasis (M)","url":null,"context":"NCIP"},{"name":"TCGA Comment","type":"COMMENT","description":"Please provide clinical evidence (often imaging) strong enough to determine patient treatment OR Histological confirmation when available","url":null,"context":"NCIP"}],"origin":"AJCC:American Joint Committee on Cancer Cancer Staging Manual, 7th Ed., 2009","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"8FBEF763-FE2D-BCFA-E040-BB89AD433126","latestVersionIndicator":"Yes","beginDate":"2010-09-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-08","modifiedBy":"TSESU","dateModified":"2018-07-17","changeDescription":"Curated for The Cancer Genome Atlas (TCGA) by request of T. Lichtenberg 9/2010","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}